News

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...
Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...
Additional research found an increased risk of gastroparesis ... Doctor Says This 1 Supplement Works Just as Well as Ozempic for Weight Loss. Most Ozempic- and Wegovy-related hospital visits were due ...
Researchers believe nearly 25,000 hospital visits occurred ... and constipation. The known risks associated with use of Ozempic are reflected in the FDA-approved product labeling." ...
The lawsuit accuses drug manufacturer Novo Nordisk of failing to warn patients of the possible association between the ...
Semaglutide (Ozempic) and tirzepatide (Zepbound) were not included in the study. Obesity is associated with 13 cancers, and losing weight can slash that risk. But the researchers found that the ...
Notably, the authors did not know whether people who visited the hospital were taking Ozempic, Wegovy ... medications to decrease hypoglycemia risk,” they wrote. “Additionally, when evaluating ...
The announcement follows new research that suggested drugs like Wegovy, Mounjaro and Ozempic slashed the risk of contracting the disease. Scientists from Israel said the drugs, also known as GLP ...
Headaches are a common and frustrating side effect some people experience while taking the popular weight loss drug Ozempic, but the medication itself may not be to blame. According to fitness and ...